Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29772250
Publication Date : //

Development and validation of a novel semi-homogenous clinical assay for quantitation of Ranibizumab in human serum.


Ranibizumab (Lucentis®), a humanized antigen-binding fragment (Fab) monoclonal antibody that blocks VEGF-A activity, is currently approved for the treatment of several retinal degenerative diseases. The assessment of drug pharmacokinetics (PK) is essential for evaluating exposure as it relates to drug safety and efficacy. For drugs administered intravitreally, systemic drug levels during the course of clinical studies are typically 100 to 1000-fold lower than those of similar therapeutics dosed intravenously, posing a significant bioanalytical challenge for PK measurements. Thus, the development of a highly-sensitive assay for measuring pg/mL levels of ranibizumab in patients' sera after intravitreal administration was needed to support clinical studies. In this report, we describe the development of a novel method that utilizes a high-affinity murine monoclonal anti-ranibizumab-VEGF-complexes antibody (MARA) reagent to measure ranibizumab in human serum. The assay format utilizes a semi-homogeneous solution phase step using a monoclonal antibody (the MARA) that binds specifically to the ranibizumab-VEGF complex, but not to either alone. This unique reagent exhibited low non-specific binding and high selectivity, increasing signal-to-noise readouts and maximizing assay sensitivity. The resulting MARA enzyme-linked immunosorbent assay (ELISA) has a lower limit of quantification of 15 pg/mL in human serum. In the assay, serum samples are incubated overnight with a mixture containing biotinylated-VEGF and MARA, which form a three-molecule complex with ranibizumab in the sample. These complexes are then captured onto streptavidin-coated wells, followed by enzymatic detection using a horseradish peroxidase-labeled-anti-murine antibody reagent and a colorimetric reaction. The assay conditions were optimized to allow for quantitative detection of "total" ranibizumab levels in serum. The assay was fully validated, establishing its high tolerance to sample matrix, as well as its suitable specificity, accuracy, dilution linearity, as well as intra- and inter-assay precision. The MARA ELISA's novel and unique approach has resulted in a considerably more sensitive ranibizumab PK assay compared to earlier versions of this assay. The MARA ELISA has been used for PK measurements in multiple ranibizumab studies, supporting this drug's life-cycle management and related preclinical and clinical-development studies.

Authors : Lowe John , Wakshull Eric , Shek Theresa , Chuntharapai Anan , Elliott Rebecca , Rusit Jeriza , Maia Mauricio ,

Related products :

Catalog number Product name Quantity
CUST-PROD Custom Immunoassay Development Program Assay Development
GENCatalog # FLU6230 Flu Vaccine ♦ Clinical Validation Panels 26 Specimens 1.0ml
GENCatalog # PM6310 Post Menopausal Women ♦ Clinical Validation Panels 25 Specimens 1.0ml
GENCatalog # CN6710 Clinically Defined "Normal" ♦ Clinical Validation Panels 25 Specimens 2.0ml
Coralab3000 Semi Automatic Clinical Chemistry Analyzer 1 pc.
BE-20 Endotoxin Assay Kit (Kinetic-Turbidimetric method, clinical diagnosis for human) 20 tests/kit
STA-330-5 OxiSelect™ TBARS Assay Kit (MDA Quantitation) 5 x 200 assays
STA-330-5 OxiSelect™ TBARS Assay Kit (MDA Quantitation) 5 x 200 assays
STA-330 OxiSelect™ TBARS Assay Kit (MDA Quantitation) 200 assays
STA-330 OxiSelect™ TBARS Assay Kit (MDA Quantitation) 200 assays
K349-100 PicoProbe™ NADPH Quantitation Fluorometric Assay Kit 100 assays
STA-330-T OxiSelect™ TBARS Assay Kit (MDA Quantitation), Trial Size 20 assays
V-1030VN-P 63 plates (96-well) Related Item A : Validation Primer VN-Fusion Library Validation Primer Set
GWB-1E79F9 Human Serum Albumin (HSA) ELISA Quantitation Kit
5524 Amplite™ Fluorimetric Thiol Quantitation Assay Kit *Green Fluorescence* 1 kit
5524 Amplite™ Fluorimetric Thiol Quantitation Assay Kit *Green Fluorescence* 1 kit
S61002 FP Assay Development Service Pack I *Red FP tracer with lifetime of 25 ns* 1 service
A1310 K01 Amplite™ Fluorimetric Total Thiol Quantitation Assay Kit *Green Fluorescence* 200 Tests
5524 Amplite Fluorimetric Total Thiol Quantitation Assay Kit *Green Fluorescence* 200 Tests
orb61218 Belinostat Belinostat (aka PXD101) is TopoTarget's lead product that is currently in late-stage clinical development for the treatment of hematological malignancies and solid tumors. For research use 10 mg
1121-03 EXP Blanc sur semi Tranparent _ EXP Wit op Semi Transparant AF Systems Consumables;Pack-PK; 4 Pcs Per Pack
S61001 FP Assay Development Service Pack I *Green FP tracer with lifetime of 15 ns* 1 service
A1310 K01 Amplite™ Rapid Fluorimetric Total Thiol Quantitation Assay Kit *Green Fluorescence* 200 Tests
5528 Amplite Rapid Fluorimetric Total Thiol Quantitation Assay Kit *Green Fluorescence* 200 Tests
31028 AccuClear Ultra High Sensitivity dsDNA Quantitation Assay kit with 8 DNA Standards (1000 assays) 1 kit


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur